Home > Insider Trading > Filing (0001209191-23-033419)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1812364	Relay Therapeutics Inc.	RLAY	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818261	Thomas Catinazzo	C/O Relay Therapeutics, Inc. 399 Binney Street, 2Nd Floor Cambridge MA 02139	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-04-28	2,012	$11.16	148,123	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed to correct the number of shares sold to cover the reporting person's income tax withholding obligations upon the vesting of 5,722 shares of restricted stock units ("RSUs") on April 27, 2023, which was inadvertently understated in the reporting person's original Form 4. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
Due to the error described above, the reporting person's original Form 4 incorrectly reported that the number of shares held by the reporting person was 149,272, including 136,049 shares underlying RSUs. As reported in this amendment, the correct number of shares held by the reporting person is 148,123, including 132,781 shares underlying RSUs.